Abstract 51: Association of Pre-Transplant Hypertensive End Stage Kidney Disease With Post-Kidney Transplant Blood Pressure
Hypertension · 2026-10 · 83 (Suppl_1)
DOI: 10.1161/hyp.83.suppl_1.51 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hypertension, 2026-10. Verfasst von Natee Deepan und 31 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Hypertension (HTN) is a leading cause of end-stage kidney disease (ESKD) and a major risk factor for cardiovascular disease post-transplant. Whether HTN as a cause of ESKD influences post-transplant blood pressure (BP) trajectories remains unclear. This study compared absolute systolic (SBP) and diastolic blood pressure (DBP) differences over 12 months in kidney transplant recipients (KTRs) between those with and without underlying HTN as the cause of ESKD.
Method
A single-center retrospective longitudinal cohort study included patients with ESKD who underwent kidney transplantation between 2024 and 2025. The patients were stratified into two groups based on ESKD etiology, HTN and non-HTN (diabetes mellitus (DM), glomerular diseases, polycystic kidney disease, and other etiologies). Absolute differences in SBP and DBP at 6, 9, and 12 months were compared with BP readings at 3 months post-transplant by multivariable linear regression analyses at each time point, adjusted for age, sex, race, presence of pre-transplant HTN, DM, coronary artery disease (CAD), stroke, and peripheral arterial disease (PAD).
Result
Among 72 KTRs, the mean age was 50.3 years, 42 (58.3%) were male, and the mean body mass index was 27.0 kg/m 2 . Race distribution included 27 (37.5%) White, 11 (15.3%) Asian, 4 (5.6%) Black or African American, and 30 (41.7%) unknown race (Table 1). Recipients with HTN-ESKD had significantly higher SBP at 9 and 12 months compared with their SBP at 3 months, with estimated increases of 24.73 and 36.41 mmHg, respectively (βSBP 9 mo [95% CI] 24.73 [0.68, 48.78]; P = 0.048; βSBP 12 mo 36.41 [9.60, 63.22]; P = 0.010). In contrast, non-HTN-ESKD recipients had lower SBP at 9 and 12 months (βSBP 9 mo –18.4 [-28.67, -8.13]; P < 0.001; βSBP 12 mo –12.6 [-23.13, -2.07]; P = 0.023). HTN-ESKD was also associated with higher DBP at 9 and 12 months, with increases in DBP of 16.01 and 18.38 mmHg, respectively (βDBP 9 mo 16.01 [4.88, 27.14]; P = 0.0065; βDBP 12 mo 18.38 [5.42, 31.34]; P = 0.0074), whereas no significant DBP changes were observed in the non-HTN group. Additionally, DM was independently associated with higher SBP and DBP at both 9 and 12 months (βSBP 9 mo 12.7 [5.04, 20.36]; P = 0.002; βDBP 9 mo 3.92 [0.37, 7.14]; P = 0.034; βSBP 12 mo 15.6 [7.78, 23.42]; P < 0.001; βDBP 12 mo 6.69 [2.91, 10.47]; P = 0.001) (Figure 1). Other covariates were not independently associated with BP changes after adjustment.
Conclusion
Post-transplant BP changes are associated with ESKD etiology. HTN-ESKD is associated with progressive rise in both SBP and DBP, while non-HTN etiologies are associated with lower SBP within the one-year post-transplant period. Comorbid DM independently worsens BP. This study highlights the importance of risk-stratified BP management in KTRs based on pre-transplant etiology of ESKD.
Zitieren
APA
Deepan, N., Rirermsoonthorn, P., Ansusinha, P., Tangprasittichok, N., Kitlertbanchong, N., Asawaroekwisoot, T., Ngamvirojcharoen, B., Chamnarnphol, N., Chongthanadon, B., Limpiwattakee, S., Bussaracom, A., Samchusri, S., Silprasert, R., Noree, W., Paisarntanawat, N., Chuenchaem, U., Soontrapornchai, P., Liengswangwong, K., Nguyen, P., …, & Tantisattamo, E. (2026). Abstract 51: Association of Pre-Transplant Hypertensive End Stage Kidney Disease With Post-Kidney Transplant Blood Pressure. Hypertension, 83(Suppl_1). https://doi.org/10.1161/hyp.83.suppl_1.51
Vancouver
Deepan N, Rirermsoonthorn P, Ansusinha P, Tangprasittichok N, Kitlertbanchong N, Asawaroekwisoot T, et al. Abstract 51: Association of Pre-Transplant Hypertensive End Stage Kidney Disease With Post-Kidney Transplant Blood Pressure. Hypertension. 2026;83(Suppl_1). doi:10.1161/hyp.83.suppl_1.51
BibTeX
@article{Deepan2026,
author = {Deepan, Natee and Rirermsoonthorn, Pawaruj and Ansusinha, Parinda and Tangprasittichok, Nathasith and Kitlertbanchong, Nitchanan and Asawaroekwisoot, Thanin and Ngamvirojcharoen, Boonyasit and Chamnarnphol, Natanon and Chongthanadon, Brandon and Limpiwattakee, Suppalux and Bussaracom, Ajirapa and Samchusri, Supawit and Silprasert, Raynah and Noree, Wanprapit and Paisarntanawat, Nont and Chuenchaem, Urairat and Soontrapornchai, Panida and Liengswangwong, Kaewkwan and Nguyen, Phat and Chartpattananan, Kaninart and Chalermchat, Thanasin and Mohpichai, Nopavit and Pleanrungsi, Darinorn and Siwawut, Katanyu and Buadee, Settawut and Kasebuthtaweewat, Yodsaphong and Vutthikraivit, Possawat and Rochanaroon, Voramol and Bunyawannukul, Issaree and Kookanok, Chutawat and Kulthamrongsri, Narathorn and Tantisattamo, Ekamol},
title = {Abstract 51: Association of Pre-Transplant Hypertensive End Stage Kidney Disease With Post-Kidney Transplant Blood Pressure},
journal = {Hypertension},
year = {2026},
volume = {83},
number = {Suppl_1},
doi = {10.1161/hyp.83.suppl_1.51}
}
EUVIMED